Anne Bollaerts
GlaxoSmithKline (Belgium)(BE)
Publications by Year
Research Areas
Tuberculosis Research and Epidemiology, Immunodeficiency and Autoimmune Disorders, Malaria Research and Control, Pneumocystis jirovecii pneumonia detection and treatment, vaccines and immunoinformatics approaches
Most-Cited Works
- → Final Analysis of a Trial of M72/AS01 E Vaccine to Prevent Tuberculosis(2019)569 cited
- → Phase 2b Controlled Trial of M72/AS01 E Vaccine to Prevent Tuberculosis(2018)397 cited
- → Induction and Regulation of T-Cell Immunity by the Novel Tuberculosis Vaccine M72/AS01 in South African Adults(2013)115 cited
- → A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive Adults(2013)96 cited
- → Safety and immunogenicity of the M72/AS01 E candidate tuberculosis vaccine in adults with tuberculosis: A phase II randomised study(2016)75 cited
- → Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial(2022)69 cited
- → Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: An open-label randomized controlled trial(2014)69 cited
- → A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults(2016)61 cited
- → Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy(2014)53 cited
- → Long-term safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in HIV-positive and -negative Indian adults(2018)46 cited